Is your early-stage medtech company looking to meet high-quality investors or strategic partners? Our Dublin 2017 stage is your ideal chance to shine. More than 40 exceptional start-ups will present in all, and timeslots are almost sold out - apply today!
International Start-Ups Interested in Competing Read More and Apply Here Before March 22, 2017!
In the December 22, 2016 issue of The MedTech Strategist, David Cassak interviewed Paul Grand, MedTech Innovator CEO, about the growth of the popular program, its role in the eco-system of medtech start-ups, and plans for the future.
Whether you’re attending or following our highly anticipated Dublin 2017 event, keep up with all the action and connect with other meeting attendees on Twitter!
“David Cassak and Stephen Levin, through their publications and conferences, have become the preeminent source for medtech information and collaboration. They possess an unmatched combination of product/sector intelligence with access to the thought leaders and innovators at every stage of development, all of which is reflected in their publication, The MedTech Strategist.”
Stan is confirmed as a guest panelist on our Dublin 2017 "Jumpstarting Growth in 2017: The Strategic Investment Perspective" panel on Tuesday, April 25th.
Vice President, Discovery
This exceptional investment and networking event – recognized by the medical device industry as the leading medical technology investment forum in Europe – is taking place April 25th through 27th, 2017, at the historic and centrally located Shelbourne Hotel, Dublin, overlooking St. Stephen’s Green. DUBLIN 2017 is hosted by The MedTech Strategist, along with our top-tier supporters including Platinum Sponsors Johnson & Johnson, Medtronic, Seroba, Enterprise Ireland, EY, Medmarc, and Eugene F. Collins; Gold Sponsors AIB, AdvaMed, CBSET, Databean, genae, Greenleaf Health, ICON, IMMR, iO Life Science, the Irish Medtech Association/Ibec, Lightstone Ventures and PMI; and Media Partners Biotechgate/Venture Valuation, Medtech Engine, and MedTech Europe.
Our team, including David Cassak and Stephen Levin, co-editors-in-chief of The MedTech Strategist, have more than 25 years of experience in organizing and hosting top-tier medtech investment and networking events, including the highly regarded DUBLIN 2015 and 2016 events. We are planning a world-class program for DUBLIN 2017! The two-and-a-half-day forum will feature presentations by 40+ early-stage medical device companies from around the world, along with thought-leading guest speakers, on-stage interviews with key device executives and VCs, and insightful and timely panel discussions, all providing candid insight on topics of utmost importance to all stakeholders in the rapidly evolving global device marketplace. Our event will also feature the popular and exciting MedTech Innovator start-up competition, hosted by Paul Grand, CEO (note: the deadline to apply for the Apr. 26th competition is March 22, 2017). See the full Event Agenda here.
Our DUBLIN 2016 attendee list included many of the top medical device VCs and senior business development executives from Ireland, many other European countries, the U.S., Asia, and beyond, along with management teams from many of the most promising start-ups in the device space. This year's attendee list will include a top-notch audience of 350+ senior-level executives from the global device industry: see our regularly updated 2017 participating company list here.
Interested in presenting, sponsoring or attending? Contact us today!
Presentations by 42+ Hand-Selected Start-Up Medical Device Companies seeking investment and/or partnership, followed by breakout sessions
- Presenters confirmed to date are listed here; start-ups apply to present here – timeslots will sell out soon!
Strategic, Venture Capital, Entrepreneur and New Funds Panel Discussions - Unparalleled access to top-tier global medtech VCs and entrepreneurs discussing their perspectives and investment strategies/experiences, moderated by The MedTech Strategist Co-Editors-in-Chief, David Cassak and Stephen Levin
Spotlight Sessions – Candid discussions with medtech thought leaders on a variety of timely topics impacting industry stakeholders from around the world, moderated by The MedTech Strategist Co-Editors-in-Chief, David Cassak and Stephen Levin
- Albert Lauritano, Director, Strategic Technology Partnerships, BD Technologies
- Mirren Mandalia, Senior Director New Ventures & Transactions, Johnson & Johnson Innovation
- Anne Sissel, Vice President and Head, Baxter Ventures
Interested Start-Ups Read More and Apply Here BEFORE MARCH 15, 2017!
Partnering via the JUJAMA app
Networking Breaks, Breakfasts, Lunches, and Evening Cocktail Receptions